First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses (Q35941261)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses
scientific article

    Statements

    First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses (English)
    Wendy Painter
    Alice Robertson
    Lawrence C Trost
    Susan Godkin
    Bernhard Lampert
    George Painter
    5 March 2012
    2726-2734

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit